Strepococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine

Details for Australian Patent Application No. 2003251694 (hide)

Owner Intervet International B.V.

Inventors Hansen, Selma Marianne; Nuijten, Petrus Johannes Maria

Agent Spruson & Ferguson

Pub. Number AU-B-2003251694

PCT Number PCT/EP03/08704

PCT Pub. Number WO2004/018683

Priority 02078325.4 12.08.02 EP

Filing date 6 August 2003

Wipo publication date 11 March 2004

Acceptance publication date 17 September 2009

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 39/09 (2006.01) Medicinal preparations containing antigens or antibodies - Streptococcus

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/315 (2006.01) Peptides having more than 20 amino acids

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 02078325.4 12.08.02 EP

22 April 2004 Application Open to Public Inspection

  Published as AU-B-2003251694

16 November 2006 Assignment before Grant

  Akzo Nobel N.V. The application has been assigned to Intervet International B.V.

17 September 2009 Application Accepted

  Published as AU-B-2003251694

21 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003251695-NOVEL THIOPHENE DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

2003251693-PYRIDAZINONE-DERIVATIVES AS PDE4 INHIBITORS